Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy

NCT03882021 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03882021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03882021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2019
Completion date
January 13, 2022
Enrollment
300 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmia, paroxysmal atrial fibrillation, persistent atrial fibrillation